...
首页> 外文期刊>Revista do Instituto de Medicina Tropical de So Paulo >CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS
【24h】

CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS

机译:控制麻风病的化学预防药及其在巴西的实施前景:非流行病学家的首选

获取原文
           

摘要

The occurrence of leprosy has decreased in the world but the perspective of its elimination has been questioned. A proposed control measure is the use of post-exposure chemoprophylaxis (PEP) among contacts, but there are still questions about its operational aspects. In this text we discuss the evidence available in literature, explain some concepts in epidemiology commonly used in the research on this topic, analyze the appropriateness of implementing PEP in the context of Brazil, and answer a set of key questions. We argue some points: (1) the number of contacts that need to receive PEP in order to prevent one additional case of disease is not easy to be generalized from the studies; (2) areas covered by the family health program are the priority settings where PEP could be implemented; (3) there is no need for a second dose; (4) risk for drug resistance seems to be very small; (5) the usefulness of a serological test to identify a higher risk group of individuals among contacts is questionable. Given that, we recommend that, if it is decided to start PEP in Brazil, it should start on a small scale and, as new evidence can be generated in terms of feasibility, sustainability and impact, it could move up a scale, or not, for a wider intervention.
机译:世界范围内麻风病的发病率有所下降,但消除麻风病的前景受到质疑。拟议的控制措施是在接触者之间使用接触后化学预防(PEP),但仍存在有关其操作方面的问题。在本文中,我们讨论了文献中可用的证据,解释了该主题研究中常用的流行病学一些概念,分析了在巴西背景下实施PEP的适当性,并回答了一系列关键问题。我们认为有以下几点:(1)不容易从研究中概括出需要接受PEP以预防另一例疾病的接触者的数量; (2)家庭健康计划所涵盖的领域是可以实施PEP的优先领域; (3)不需要第二剂; (4)耐药性的风险似乎很小; (5)血清学检测在接触者中识别高风险人群的有用性值得怀疑。有鉴于此,我们建议,如果决定在巴西启动PEP,则应从小规模开始,并且由于可以在可行性,可持续性和影响方面产生新的证据,因此可以扩大规模,也可以不扩大规模。 ,以进行更广泛的干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号